BioMILD is a multicenter project for lung cancer early detection. BioMILD project is open to people at high risk of lung cancer, men and women older than 50 years, heavy smokers or former smokers having stopped from 10 years or less. Participation in BioMILD trial is free.
The SIUrO-PRIAS-ITA project is based on the experience of 8 Italian centers in the PRIAS (Prostate Cancer Research International: Active Surveillance) international collaborative study on active surveillance (AS).
AS is being validated as an alternative to radical therapies for low risk prostate cancer (PC). The aim of PRIAS is to deal with the issue of overdiagnosis resulting from PSA based opportunistic screening, limit overtreating potentially indolent PC and avoid therapy-induced side effects.
Copyright © 2017 INT
Fondazione IRCCS Istituto Nazionale dei Tumori
All rights reserved
website by Studio Luvié